Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 20:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- ZAR 86.53T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | ZAR 87.1B | ZAR 248.29 | 3.27% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | ZAR 163B | ZAR 1,716.55 | 3.17% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | ZAR 116.3B | ZAR 1,714.19 | 2.47% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | ZAR 90.6B | ZAR 2,147.08 | 1.59% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | ZAR 70.7B | ZAR 516.76 | 1.56% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | ZAR 128.4B | ZAR 1,633.90 | 1.62% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | ZAR 171.4B | ZAR 1,134.17 | 1.83% down | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | ZAR 84.2B | ZAR 1,495.25 | 1.90% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | ZAR 398.9B | ZAR 347.98 | 1.80% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | ZAR 495.6B | ZAR 684.07 | 1.08% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | ZAR 130B | ZAR 373.22 | 2.38% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | ZAR 153B | ZAR 5,472.90 | 2.63% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | ZAR 79.3B | ZAR 723.91 | 0.15% up | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | ZAR 681.5B | ZAR 1,185.19 | 1.22% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | ZAR 795.9B | ZAR 682.15 | 7.55% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | ZAR 551.4B | ZAR 894.27 | 0.41% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | ZAR 136.1B | ZAR 809.87 | 1.07% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | ZAR 1.2T | ZAR 374.88 | 0.87% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | ZAR 142.6B | ZAR 2,184.65 | 1.68% down | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | ZAR 100.3B | ZAR 5,012.66 | 3.96% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | ZAR 5.67T | ZAR 2,300.85 | 4.43% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | ZAR 80.5B | ZAR 838.70 | 4.46% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | ZAR 108.3B | ZAR 2,665.42 | 2.36% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | ZAR 264.6B | ZAR 4,122.58 | 4.77% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | ZAR 11.18T | ZAR 4,644.68 | 2.52% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | ZAR 108.9B | ZAR 1,668.85 | 3.27% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | ZAR 21.02T | ZAR 23,597.84 | 2.33% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | ZAR 2.08T | ZAR 1,015.71 | 2.40% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | ZAR 293.6B | ZAR 4,476.24 | 5.23% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | ZAR 1.67T | ZAR 16,179.84 | 2.07% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | ZAR 2.3T | ZAR 9,077.06 | 3.16% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | ZAR 232.1B | ZAR 464.43 | 0.45% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | ZAR 4.98T | ZAR 2,636.50 | 2.78% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | ZAR 8.72T | ZAR 4,932.46 | 1.30% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | ZAR 418.5B | ZAR 9,826.83 | 2.59% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | ZAR 266.7B | ZAR 1,369.19 | 0.45% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | ZAR 141.6B | ZAR 2,042.68 | 1.79% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | ZAR 209.8B | ZAR 1,082.98 | 0.90% up | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | ZAR 797.3B | ZAR 6,979.77 | 1.03% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | ZAR 2.74T | ZAR 480.77 | 1.94% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | ZAR 106.6B | ZAR 753.79 | 0.07% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | ZAR 216.8B | ZAR 260.00 | 0.67% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | ZAR 1.67T | ZAR 834.02 | 1.75% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | ZAR 4.74T | ZAR 3,056.03 | 2.16% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | ZAR 97.9B | ZAR 143.80 | 2.83% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | ZAR 1.93T | ZAR 803.67 | 2.39% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | ZAR 124B | ZAR 2,356.76 | 0.66% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | ZAR 124.2B | ZAR 1,135.05 | 4.17% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | ZAR 3.14T | ZAR 1,813.35 | 0.67% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | ZAR 2.98T | ZAR 675.59 | 1.94% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | ZAR 125.4B | ZAR 900.38 | 0.41% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | ZAR 84.6B | ZAR 486.27 | 0.07% up | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | ZAR 85.8B | ZAR 1,027.33 | 2.38% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | ZAR 576.9B | ZAR 1,419.86 | 5.04% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | ZAR 160.6B | ZAR 6,914.16 | 0.60% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | ZAR 124.3B | ZAR 1,419.33 | 3.10% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | ZAR 148.3B | ZAR 185.39 | 1.05% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | ZAR 558B | ZAR 2,543.55 | 21.51% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | ZAR 54.6B | ZAR 281.67 | 0.80% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | ZAR 78.7B | ZAR 472.38 | 1.30% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | ZAR 348.6B | ZAR 2,602.61 | 0.30% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4730 ZAR).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 20:16 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of ZAR 86.53T as of 19 Nov 2026, 20:16 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.